SOFTGEL NLKJ FOR TREATMENT OF PROSTATE DISEASES Russian patent published in 2007 - IPC A61K36/8994 A61K31/355 A61K9/48 A61P13/08 

Abstract RU 2296581 C2

FIELD: chemical and pharmaceutical industry, medicine.

SUBSTANCE: claimed softgel contains 0.05-1.0 g of NLKJ and 0.05-1.5 of antioxidant, wherein said NLKJ has the next physical and chemical characteristics: acid value <0.56; iodine number 95.0-107.00; saponification number 186.00-195.00; specific mass 0.914-0.918 (20°C) and refractive index 1.470-1.475 (20°C) and is isolated from corns of Coix lacryma. Kit including dose of abovementioned composition also is disclosed. Inhibiting action of softgel NLKJ in combination with Luprone injection on prostate cancer growth is stronger than action of individual components.

EFFECT: softgel NLKJ with increased action on prostate cancer growth.

5 cl, 2 ex, 2 tbl

Similar patents RU2296581C2

Title Year Author Number
NEUTRAL LIPIDS FROM JOB'S TEARS GRAINS NLKY, METHOD OF THEIR PREPARING, COMPOSITION BASED ON THEREOF, NEUTRAL LIPIDS FOR USE AS A DRUG 1993
  • Da Peng Li
RU2123853C1
STONE OIL FROM STONE FRUITS, METHOD FOR EXTRACTION THE SAME, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF 2002
  • Li Dapeng
RU2285535C2
APPLYING EPOTILONES FOR CANCER TREATMENT 1999
  • O'Rajlli Terens
  • Vartmann Markus
  • Lichmehn Manuehl'
  • Koehn Pamela
RU2242229C2
USE OF THE PLINABULIN IN COMBINATION WITH THE IMMUNE RESPONSE CONTROL POINT INHIBITORS 2016
  • Khuan Lan
  • Li Gloriya Tsi-Ji
RU2723021C2
APPLICATION OF EXTRACTS OF GINSENG, GYNSENOSIDES AND DERIVATIVES OF GINSENOSIDE FOR THE PREPARATION OF MEDICAL PRODUCTS OR REMEDIES FOR THE TREATMENT OF DISORDERS CAUSED BY CMV 2016
  • Fu, Li
  • Wang, Kaiqian
  • Hui, Min
  • Li, Fan
  • Fan, Hongyu
  • Wang, Shuo
RU2679903C1
LIPOSOME DELIVERY OF COMPOSITIONS BASED ON VITAMIN E 2002
  • Sanders Bob G.
  • Klajn Kimberli
  • Louson Karla A.
  • Menchaka Marla S.
  • Najt Dzh. Vernon
  • Vellen Klajd V.
RU2328273C2
FUSED DLK1-Fc PROTEIN AND USING IT FOR METASTASES INHIBITION, POLYNUCLEOTIDE CODING PROTEIN, VECTOR, HOST CELL, METHOD FOR PRODUCING FUSED PROTEIN, COMPOSITION AND METHOD FOR METASTASES INHIBITION 2010
  • Park,Jang Voo
  • Dzo,Kivon
  • Li,Dongkhe
  • Ju,Dzung
  • Park,Dzi Khiun
  • Park,Chan Voong
  • Kim,Eun Dzin
  • Park,Jun Dzung
RU2531756C2
IMPROVED METHODS FOR TREATING TUMOURS 2007
  • Fehrklot Glinn Tomas
  • Aviles Marin Pablo Manuehl'
  • Lepazh Dorin
  • San Migel' Isk'Erdo Khesus
  • Pandiehl'Ja Atanasio
RU2481853C2
COMBINED THERAPY FOR CANCER TREATMENT 2015
  • Bao, Xingfeng
  • Albu, Diana
  • Woodall-Jappe, Mary
RU2708374C2
ANTICANCER AGENT CONTAINING LK8 PROTEIN AS ACTIVE INGREDIENT 2004
  • Ju Khiunkiung
  • Kim Dzang-Seong
  • Akhn Dzin-Khiung
  • Li Kho-Dzeong
  • Kang Kvan-Jub
  • Lim Khiung-Kvon
  • Park Dzung Khvan
  • Lim In-Khvan
  • Kim Sung Geun
  • Dzoo Khak Kiu
  • Li Dzi Khiun
  • Joon Jeup
  • Park Doo-Khong
RU2306147C2

RU 2 296 581 C2

Authors

Li Dapeng

Dates

2007-04-10Published

2003-09-22Filed